Literature DB >> 16382216

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.

Paul A Jensen1, Lauren A Lambert, Michael F Iademarco, Renee Ridzon.   

Abstract

In 1994, CDC published the Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in HealthCare Facilities, 1994. The guidelines were issued in response to 1) a resurgence of tuberculosis (TB) disease that occurred in the United States in the mid-1980s and early 1990s, 2) the documentation of several high-profile health-care--associated (previously termed "nosocomial") outbreaks related to an increase in the prevalence of TB disease and human immunodeficiency virus (HIV) coinfection, 3) lapses in infection control practices, 4) delays in the diagnosis and treatment of persons with infectious TB disease, and 5) the appearance and transmission of multidrug-resistant (MDR) TB strains. The 1994 guidelines, which followed statements issued in 1982 and 1990, presented recommendations for TB infection control based on a risk assessment process that classified health-care facilities according to categories of TB risk, with a corresponding series of administrative, environmental, and respiratory protection control measures. The TB infection control measures recommended by CDC in 1994 were implemented widely in health-care facilities in the United States. The result has been a decrease in the number of TB outbreaks in health-care settings reported to CDC and a reduction in health-care-associated transmission of Mycobacterium tuberculosis to patients and health-care workers (HCWs). Concurrent with this success, mobilization of the nation's TB control programs succeeded in reversing the upsurge in reported cases of TB disease, and case rates have declined in the subsequent 10 years. Findings indicate that although the 2004 TB rate was the lowest recorded in the United States since national reporting began in 1953, the declines in rates for 2003 (2.3%) and 2004 (3.2%) were the smallest since 1993. In addition, TB infection rates greater than the U.S. average continue to be reported in certain racial/ethnic populations. The threat of MDR TB is decreasing, and the transmission of M. tuberculosis in health-care settings continues to decrease because of implementation of infection-control measures and reductions in community rates of TB. Given the changes in epidemiology and a request by the Advisory Council for the Elimination of Tuberculosis (ACET) for review and update of the 1994 TB infection control document, CDC has reassessed the TB infection control guidelines for health-care settings. This report updates TB control recommendations reflecting shifts in the epidemiology of TB, advances in scientific understanding, and changes in health-care practice that have occurred in the United States during the preceding decade. In the context of diminished risk for health-care-associated transmission of M. tuberculosis, this document places emphasis on actions to maintain momentum and expertise needed to avert another TB resurgence and to eliminate the lingering threat to HCWs, which is mainly from patients or others with unsuspected and undiagnosed infectious TB disease. CDC prepared the current guidelines in consultation with experts in TB, infection control, environmental control, respiratory protection, and occupational health. The new guidelines have been expanded to address a broader concept; health-care--associated settings go beyond the previously defined facilities. The term "health-care setting" includes many types, such as inpatient settings, outpatient settings, TB clinics, settings in correctional facilities in which health care is delivered, settings in which home-based health-care and emergency medical services are provided, and laboratories handling clinical specimens that might contain M. tuberculosis. The term "setting" has been chosen over the term "facility," used in the previous guidelines, to broaden the potential places for which these guidelines apply.

Entities:  

Mesh:

Year:  2005        PMID: 16382216

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  344 in total

1.  Latent tuberculosis infection screening for laboratory personnel using interferon-γ release assay and tuberculin skin test in Korea: an intermediate incidence setting.

Authors:  Hee-Won Moon; Hanah Kim; Mina Hur; Yeo-Min Yun; Anna Lee
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

2.  The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.

Authors:  Grant Theron; Lancelot Pinto; Jonny Peter; Hemant Kumar Mishra; Hridesh Kumar Mishra; Richard van Zyl-Smit; Surendra Kumar Sharma; Keertan Dheda
Journal:  Clin Infect Dis       Date:  2011-12-01       Impact factor: 9.079

3.  Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States.

Authors:  Manish Joshi; Thomas P Monson; Gail L Woods
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

4.  Low yield of chest radiography in a large tuberculosis screening program.

Authors:  Ronald L Eisenberg; Nira R Pollock
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

5.  Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

Authors:  Padmapriya P Banada; Satheesh K Sivasubramani; Robert Blakemore; Catharina Boehme; Mark D Perkins; Kevin Fennelly; David Alland
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

Review 6.  Transmission and Institutional Infection Control of Tuberculosis.

Authors:  Edward A Nardell
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

7.  Dispersion and exposure to a cough-generated aerosol in a simulated medical examination room.

Authors:  William G Lindsley; William P King; Robert E Thewlis; Jeffrey S Reynolds; Kedar Panday; Gang Cao; Jonathan V Szalajda
Journal:  J Occup Environ Hyg       Date:  2012       Impact factor: 2.155

8.  Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results.

Authors:  Nira R Pollock; Suely S Kashino; Danielle R Napolitano; Alex Sloutsky; Swati Joshi; Jasmine Guillet; Michael Wong; Edward Nardell; Antonio Campos-Neto
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

9.  Qualitative Analysis of Origins and Evolution of an Elastomeric Respirator-based Hospital Respiratory Protection Program.

Authors:  Stella E Hines; Nora Mueller; Marc Oliver; Patricia Gucer; Melissa McDiarmid
Journal:  J Int Soc Respir Prot       Date:  2017

10.  Rapid Identification of Mycobacterium tuberculosis and nontuberculous mycobacteria by multiplex, real-time PCR.

Authors:  E T Richardson; D Samson; N Banaei
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.